CD4 and neoplasm: This finding may help explain the contradictory results observed in predicting the prognosis of tumor ICI treatment based on baseline HLA-DR + CD3 + T cells, where baseline HLA-DR + CD4 + T cells predict a positive outcome, while HLA-DR + CD8 + T cells indicate the opposite.